Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Impairment Based Treatment Versus Modified Functional Restoration Program in Chronic Low Back Pain Patients (FIRM-CLBP)

7 luglio 2026 aggiornato da: Mariam Wael Mohamed, Cairo University

FIRM-CLBP: a Randomized Controlled Feasibility Trial Comparing Impairment-based Treatment With a Modified Functional Restoration Program in Older Adults With Chronic Low Back Pain

The aim of this feasibility study is to evaluate the practicality of conducting a future randomized controlled trial comparing two rehabilitation approaches for older adults with degenerative chronic low back pain: impairment-based treatment (IBT) and a modified short Functional Restoration Program (FRP).

Impairment-based treatment is an individualized approach in which interventions are tailored to the patient's specific physical deficits, such as limitations in mobility, strength, and motor control. In contrast, the Functional Restoration Program is a structured, standardized approach focusing on improving overall functional capacity through progressive exercise, movement retraining, and activity-based rehabilitation.

Participants will be randomly allocated to one of the two groups. Both interventions will be delivered by trained physiotherapists following standardized protocols over a 6-week period, with supervised sessions conducted according to a predefined rehabilitation schedule.

Panoramica dello studio

Tipo di studio

Interventistico

Iscrizione (Stimato)

18

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

  • Nome: Mariam Wael, Bachelor of physiotherapy
  • Numero di telefono: 201117614968
  • Email: merowael14@gmail.com

Luoghi di studio

    • Cairo Governorate
      • Cairo, Cairo Governorate, Egitto
        • Recovery City Clinic

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Adulto
  • Adulto più anziano

Accetta volontari sani

Sì

Descrizione

Inclusion Criteria:

  • ≥ 60 years
  • Chronic Non-Specific Low Back Pain (CNSLBP)
  • Pain duration ≥ 12 weeks
  • No identifiable specific spinal pathology
  • Pain Location
  • Pain localized between the 12th rib and gluteal folds
  • With or without non-dermatomal referred pain not extending below the knee
  • Pain Intensity
  • Mean pain intensity ≥ 4/10 on the Numeric Rating Scale (NRS) over the past 7 days
  • Functional Disability
  • Oswestry Disability Index (ODI) ≥ 20% (moderate disability or higher)
  • Mechanical Pain Characteristics
  • Presence of ≥ 2 of the following:
  • Pain aggravated by movement, loading, or prolonged postures
  • Pain relieved by rest or positional change
  • Morning stiffness < 30 minutes
  • Absence of constant, non-mechanical night pain Functional Capacity
  • Able to ambulate independently (with or without assistive device)
  • Able to actively participate in an exercise-based rehabilitation program
  • Clinical Stability
  • Stable medication regimen (analgesics, anti-inflammatories, or related drugs) for ≥ 4 weeks
  • No planned changes in pharmacological treatment during the study period
  • Cognitive & Communication Ability
  • Able to understand study procedures and follow instructions
  • MMSE ≥ 24 (or equivalent cognitive screening)
  • Consent
  • Provides written informed consent

Exclusion Criteria:

  • 1. Specific Spinal Pathology ("Red Flags")

    • Suspected or confirmed:
    • Spinal fracture
    • Malignancy
    • Spinal infection
    • Inflammatory spondyloarthropathy

Clinical indicators:

Unexplained weight loss Fever or systemic illness History of significant trauma

2. Radicular or Neurological Involvement

  • Radiculopathy defined by ANY of:
  • Dermatomal pain radiating below the knee
  • Progressive motor weakness
  • Objective neurological deficit (sensory, reflex, or motor)

    3. Lumbar Spinal Stenosis (Severe)

  • Neurogenic claudication limiting walking to < 100 meters, OR
  • Symptoms not relieved by rest or flexion

    4. Prior Surgical or Structural Conditions Lumbar spine surgery within the past 12 months

    5. Medical Contraindications to Exercise

  • Severe osteoporosis with high fracture risk
  • Uncontrolled cardiovascular, respiratory, or metabolic disease
  • Any condition precluding safe participation in rehabilitation

    6. Cognitive or Behavioral Barriers

  • Severe cognitive impairment (MMSE < 24)
  • Inability to comply with study procedures

    7. Confounding Treatment Factors

  • Participation in structured physiotherapy or rehabilitation within the past 3 months
  • Planned concurrent rehabilitation during the study

    8. Psychosocial Confounders Ongoing litigation or compensation claims related to low back pain

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Trattamento
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Separare

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Comparatore attivo: Impairment-based treatment group
Subgroup 1 - Lumbar Mobility Deficits Clinical characteristics Localized low back pain Restricted lumbar range of motion Segmental hypomobility Pain at end-range movement Stiffness with prolonged posture Subgroup 2 - Movement Coordination Impairment Clinical characteristics Recurrent low back pain Pain aggravated by movement Poor trunk control Difficulty maintaining neutral spine Aberrant movement patterns during functional tasks Subgroup 3 - Low Back Pain with Referred Lower Extremity Pain (Non-Radicular) Clinical characteristics Low back pain associated with referred pain to the buttock or thigh (above the knee) No neurological deficit on examination Symptoms influenced by movement or loading Mechanical pain behavior
Comparatore attivo: Modified short functional restoration program

The modified short Functional Restoration Program (FRP) is a structured, time-efficient rehabilitation approach designed to improve functional capacity in patients with chronic low back pain. It is based on a biopsychosocial model and combines progressive physical reconditioning with functional task training and patient education. The program includes aerobic conditioning, strengthening exercises, movement retraining, and graded activity exposure, with emphasis on restoring tolerance to daily activities rather than focusing solely on pain reduction.

In this modified short version, the program is adapted for older adults and delivered over a limited timeframe, with standardized session content and progression criteria to ensure consistency, safety, and feasibility within a clinical outpatient setting.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Pain intensity
Lasso di tempo: Baseline (week =zero) Intervention Mid Intervention (week 2) Post intervention (week 6) Follow up (1 month post intervention)
-Numerical pain rating scale (NPRS) from 1 to 10 , minimum 1 and maximum 10 . The bigger the numbers means the worse .
Baseline (week =zero) Intervention Mid Intervention (week 2) Post intervention (week 6) Follow up (1 month post intervention)
Function
Lasso di tempo: Baseline (week =zero) Intervention Mid Intervention (week 2) Post intervention (weak 6) Follow up (1 month post intervention)

Modified Oswestry disability Index

the MOLBPDQ consists of 10 patient-completed questions in which the response options are presented as 6-point Likert scales. Scores range from 0% (no disability) to 100% (most severe disability).

Baseline (week =zero) Intervention Mid Intervention (week 2) Post intervention (weak 6) Follow up (1 month post intervention)
Strength
Lasso di tempo: Baseline (week =zero) Intervention Mid Intervention (week 2) Post intervention (week 6) Follow up (1 month post intervention)
Hand held dynamometer (activ force 2)
Baseline (week =zero) Intervention Mid Intervention (week 2) Post intervention (week 6) Follow up (1 month post intervention)
Eligibility rate
Lasso di tempo: Post intervention (week 6)

Eligibility rate will be calculated as the proportion of screened participants who meet the study eligibility criteria. All individuals assessed for participation will be recorded, including those who are eligible and those who are excluded with reasons for exclusion.

Eligibility Rate (%) = Number of Eligible Participants ÷ Number of Screened Participants × 100

Post intervention (week 6)
Retention
Lasso di tempo: Post intervention (week 6) Follow up (1 month post intervention)

Participant Retention Rate

Description:

Percentage of enrolled participants who complete the study through the final follow-up assessment, as determined from study participation and completion records.

Unit of Measure:

Percentage (%)

Measurement Tool:

Study participation and completion records

Post intervention (week 6) Follow up (1 month post intervention)
Intervention fidelity
Lasso di tempo: Post intervention (week 6)

Percentage of predefined treatment components delivered according to the study protocol, as assessed using a standardized intervention fidelity checklist completed by an independent assessor during treatment sessions. Fidelity scores will be calculated as the proportion of protocol-required components successfully delivered.

Unit of Measure:

Percentage (%)

Measurement Tool:

Standardized Intervention Fidelity Checklist

Post intervention (week 6)
Recruitment feasibility
Lasso di tempo: Post intervention (weak 6)
Determine the recruitment rate (number of eligible and consenting participants per month) among older adults with degenerative chronic low back pain recruited from the clinical setting
Post intervention (weak 6)
Safety outcome
Lasso di tempo: every session
The incidence, type, severity, and relatedness of any adverse events or undesirable effects potentially attributable to the rehabilitation intervention will be monitored and documented throughout the study period. Adverse events may include increased pain, excessive fatigue, symptom aggravation, dizziness, discomfort during or after treatment, or any other unexpected clinical complaint reported by the participant or observed by the therapist.
every session
Data completeness
Lasso di tempo: Baseline (week zero) post-intervention: Week 6 Follow-up: 1 month post-intervention
Data completeness will be assessed by calculating the proportion of completed outcome assessments at each assessment point out of the total expected outcome assessments. Missing or incomplete data will be recorded and reported.
Baseline (week zero) post-intervention: Week 6 Follow-up: 1 month post-intervention

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Adherence
Lasso di tempo: Post intervention (week 6)

Participant adherence will be assessed throughout the intervention period using session attendance records, completion of the prescribed exercise program, and therapist documentation. Attendance adherence will be calculated as the percentage of attended treatment sessions out of the total scheduled sessions. Home exercise adherence will be monitored using a patient exercise diary or checklist, where participants record the frequency of performed exercises. Overall adherence will be considered acceptable when the participant completes at least 80% of the scheduled sessions and prescribed home exercises.

Adherence rate will be calculated using the following formula:

Adherence Rate (%) = Number of Completed Sessions or Exercises ÷ Total Prescribed Sessions or Exercises × 100

Post intervention (week 6)
Quality of Life outcome
Lasso di tempo: Baseline (week =zero) Intervention Mid Intervention (week 2) Post intervention (week 6) Follow-up (1 month post-intervention)
Short Form 12 Item Health Survey Sf-12 , when the score gets higher it means better outcome.
Baseline (week =zero) Intervention Mid Intervention (week 2) Post intervention (week 6) Follow-up (1 month post-intervention)
Range of motion
Lasso di tempo: Baseline (week =zero) Intervention Mid Intervention (week 2) Post intervention (weak 6) Follow up (1 month post intervention)
Goniometer
Baseline (week =zero) Intervention Mid Intervention (week 2) Post intervention (weak 6) Follow up (1 month post intervention)
Pressure pain threshold
Lasso di tempo: Baseline (week =zero) Intervention Mid Intervention (week 2) Post intervention (weak 6) Follow up (1 month post intervention)
Pressure pain threshold will be measured by pressure algometer using Kilogram as a unit of measurement.
Baseline (week =zero) Intervention Mid Intervention (week 2) Post intervention (weak 6) Follow up (1 month post intervention)
Acceptability
Lasso di tempo: Post-intervention: Week 6 Follow-up: 1 month post-intervention
Acceptability will be assessed using participant feedback regarding the practicality, ease of use, burden, and overall acceptability of the study procedures and measurement tools. Feedback may be collected using a brief questionnaire, rating scale, or structured interview.
Post-intervention: Week 6 Follow-up: 1 month post-intervention

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

1 luglio 2026

Completamento primario (Stimato)

1 novembre 2026

Completamento dello studio (Stimato)

10 gennaio 2027

Date di iscrizione allo studio

Primo inviato

28 aprile 2026

Primo inviato che soddisfa i criteri di controllo qualità

7 luglio 2026

Primo Inserito (Effettivo)

13 luglio 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

13 luglio 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

7 luglio 2026

Ultimo verificato

1 luglio 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • FIRM-CLBPstudy

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi